ELIZABETH SWAN: Open Payments
NPI 1528097854 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 14 payments from 11 companies in 2025. Trend: 2023 $611 · 2024 $220 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $53 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
| ABBVIE INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| AERIN MEDICAL INC. | 1 | $21 |
| Sequel Med Tech, LLC | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| Abbott Laboratories | 1 | $15 |
Products named: GARDASIL 9, Wegovy, JARDIANCE, Veozah, Saxenda, QULIPTA, BREZTRI, VIVAER STYLUS.
Industry payments across MD — which companies pay providers there.
